Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TAK and other ETFs, options, and stocks.

About TAK

Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following business divisions: Gastrointestinal Diseases, Rare Diseases, Plasma-Derived Therapies, Oncology, Vaccines, and Neuroscience The company was founded by Takeda Chobei on June 12, 1781 and is headquartered in Osaka, Japan. 

CEO
Julie So-Young Kim
CEOJulie So-Young Kim
Employees
47,029
Employees47,029
Headquarters
Osaka, Osaka
HeadquartersOsaka, Osaka
Founded
1781
Founded1781
Employees
47,029
Employees47,029

TAK Key Statistics

Market cap
56.79B
Market cap56.79B
Price-Earnings ratio
-53.28
Price-Earnings ratio-53.28
Dividend yield
3.31%
Dividend yield3.31%
Average volume
3.61M
Average volume3.61M
High today
$17.66
High today$17.66
Low today
$17.48
Low today$17.48
Open price
$17.49
Open price$17.49
Volume
3.14M
Volume3.14M
52 Week high
$18.90
52 Week high$18.90
52 Week low
$12.99
52 Week low$12.99

TAK News

TipRanks 3d
Takeda Targets China PV Market With New Rusfertide Trial

Takeda Pharmaceutical Company (TAK) announced an update on their ongoing clinical study. Unlock powerful investing tools with TipRanks Premium to make smarter,...

TipRanks 4d
Top Takeda Executives Quietly Unload Significant Stakes in Major Stock Move

New insider activity at Takeda Pharmaceutical Company ( (TAK) ) has taken place on August 12, 2026. Claim 55% Off TipRanks Unlock powerful investing tools with...

24/7 Wall St. 6d
A Profitable Rare-Disease Prize: Who Might Snap Up BioCryst?

A Profitable Rare-Disease Prize: Who Might Snap Up BioCryst? By Trey Thoelcke Published Aug 11, 9:20AM EDT Quick Read BioCryst hit its first full year of prof...

A Profitable Rare-Disease Prize: Who Might Snap Up BioCryst?

Analyst ratings

59%

of 17 ratings
Buy
58.8%
Hold
41.2%
Sell
0%

More TAK News

TipRanks 7d
Takeda award from Veterans Affairs posted to SAM.gov site

A contract award dated August 7 from Department of Veterans Affairs to Takeda (TAK) Pharmaceuticals America was posted to the SAM.gov website. The total contrac...

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.